Pancreatic Cancer Research

ResearcherDalian Medical UniversityNo recent work listed

Lin Luo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3361-2751; OpenAlex author ID A5100701654. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma. Co-author DOI 10.12659/msm.933443↗
  2. Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression. Co-author DOI 10.1038/ncomms14035↗
  3. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism. Co-author DOI 10.1097/01.coc.0000436088.69084.22↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guangzhen Wu · 1 shared paper, 2021 · strength 0.19
  2. Shengyu Yang · 1 shared paper, 2017 · strength 0.06
  3. Chongbiao Huang · 1 shared paper, 2017 · strength 0.06
  4. Xiuchao Wang · 1 shared paper, 2017 · strength 0.06
  5. Na Li · 1 shared paper, 2017 · strength 0.06
  6. Zengxun Li · 1 shared paper, 2017 · strength 0.06
  7. Tiansuo Zhao · 1 shared paper, 2017 · strength 0.06
  8. Jihui Hao · 1 shared paper, 2017 · strength 0.06
  9. Ji-Hui Hao · 1 shared paper, 2015 · strength 0.05
  10. Peng Jin · 1 shared paper, 2015 · strength 0.05
  11. Wei Sun · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.